Sinclair Research’s Response
to COVID-19 Pandemic
Sinclair Research announces strategic partnership with Bolder BioPATH to expand early-stage discovery model portfolio
Auxvasse, Mo. -- Sinclair Research, a leading provider of nonclinical contract research services, today announced a strategic partnership with Bolder BioPATH, a premier provider of pharmacology and pathology services specializing in in vivo models of Rheumatoid...
Sinclair Research announced the completion of successful validation of GLP ototoxicity testing services in partnership with Turner Scientific.
Sinclair Research recently expanded its GLP nonclinical toxicology facility by adding additional research space dedicated to support nonclinical toxicology research. The new expansion increases our room capacity by more than 25 percent, allowing Sinclair to continue...
I want to take the opportunity to speak to you about what Sinclair Research is doing to address the novel Coronavirus, COVID-19. First, and most importantly, I want to stress how seriously we take our role in supporting your important research. Sinclair Research takes...
Auxvasse, Mo. — Sinclair Research, a leading provider of nonclinical contract research services, will officially open its 20,000-square-foot laboratory expansion later this spring. The additional capacity will support GLP nonclinical toxicology research studies to...